1. COVID-19 Vaccination Willingness and Hesitancy in Patients With Inflammatory Bowel Diseases: Analysis of Determinants in a National Survey of the Italian IBD Patients’ Association
- Author
-
Simona Radice, Francesco Conforti, Claudio Costantino, Marina Aloi, Ferdinando Ficari, S. Leone, A. Armuzzi, Francesco Manguso, Andrea Costantino, Giammarco Mocci, Maurizio Vecchi, Loris Pironi, Ambrogio Orlando, Daniele Noviello, Alessandra Tongiorgi, Fernando Rizzello, Fabrizio Bossa, Flavio Caprioli, Costantino A., Noviello D., Conforti F.S., Aloi M., Armuzzi A., Bossa F., Ficari F., Leone S., Manguso F., Mocci G., Orlando A., Pironi L., Radice S., Rizzello F., Tongiorgi A., Costantino C., Vecchi M., Caprioli F., and Costantino Andrea, Noviello Daniele, Conforti Francesco Simone, Aloi Marina, Armuzzi Alessandro, Bossa Fabrizio, Ficari Ferdinando, Leone Salvo, Manguso Francesco, Mocci Giammarco, Orlando Amrbogio, Pironi Loris, Radice Simona, Rizzello Fernando, Tongiorgi Alessandra, Costantino Claudio, Vecchi Maurizio, Caprioli Flavio
- Subjects
medicine.medical_specialty ,2019-20 coronavirus outbreak ,COVID-19 Vaccines ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,IBD ,Brief Report - Clinical ,Internal medicine ,medicine ,Humans ,Immunology and Allergy ,In patient ,AcademicSubjects/MED00260 ,SARS-CoV-2 ,business.industry ,Vaccination ,Gastroenterology ,COVID-19 ,Inflammatory Bowel Diseases ,COVID-19 Vaccines Human ,IBD, Crohn, Ulcerative Colitis, Vaccination, Covid 19, Sars-Cov 2 ,COVID-19 vaccine ,vaccine hesitancy ,business - Abstract
The coronavirus disease 2019 (COVID-19) pandemic has not finished yet, and the most promising option towards its ending is widespread vaccination. Because patients with inflammatory bowel diseases (IBDs), namely Crohn’s disease (CD) and ulcerative colitis (UC), often require immune-modifying treatment, which might increase the risk of opportunistic infection,1 their vaccination history for several infectious diseases is routinely checked, and when inadequate, vaccination is performed at diagnosis or ideally before immune suppressive treatment is started.1 However, IBD patients were not found to be at an increased risk of developing COVID-19 or of experiencing a more severe disease course.2
- Published
- 2021
- Full Text
- View/download PDF